The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Akt, FoxO and regulation of apoptosis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Kikuno, N., Shiina, H., Urakami, S., Kawamoto, K., Hirata, H., Tanaka, Y., Place, R. F., Pookot, D., Majid, S., Igawa, M., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210572 · Cited by 207
RetractedGopinath, S., Malla, R. R., Gondi, C. S., Alapati, K., Fassett, D. R., Klopfenstein, J. D., Dinh, D. H., Gujrati, M., & Rao, J. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011668 · Cited by 33
RetractedBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
miRBase: tools for microRNA genomics
Griffiths-Jones, S., Saini, H. K., van Dongen, S., & Enright, A. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm952 · Cited by 4,382
miRBase: microRNA sequences, targets and gene nomenclature
Griffiths-Jones, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj112 · Cited by 3,950
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Hudes, G., Carducci, M., Tomczak, P., Dutcher, J., Figlin, R., Kapoor, A., Staroslawska, E., Sosman, J., McDermott, D., Bodrogi, I., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066838 · Cited by 3,647
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., et al. (2004) · Science · doi:10.1126/science.1094637 · Cited by 3,239
Motzer, R. J., Escudier, B., Oudard, S., Hutson, T. E., Porta, C., Bracarda, S., Grünwald, V., Thompson, J. A., Figlin, R. A., Hollaender, N., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61039-9 · Cited by 3,019
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Griffiths-Jones, S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh023 · Cited by 2,220
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress
Tothova, Z., Kollipara, R., Huntly, B. J., Lee, B. H., Castrillon, D. H., Cullen, D. E., McDowell, E. P., Lazo-Kallanian, S., Williams, I. R., Sears, C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.01.003 · Cited by 1,562
To cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
Medema, R. H., Kops, G. J. P. L., Bos, J. L., & Burgering, B. M. T. (2000) · Nature · doi:10.1038/35008115 · Cited by 1,438
FOXO transcription factors at the interface between longevity and tumor suppression
Greer, E. L., & Brunet, A. (2005) · Oncogene · doi:10.1038/sj.onc.1209086 · Cited by 1,310
Xiao, C., Srinivasan, L., Calado, D. P., Patterson, H. C., Zhang, B., Wang, J., Henderson, J. M., Kutok, J. L., & Rajewsky, K. (2008) · Nature Immunology · doi:10.1038/ni1575 · Cited by 1,228
PI3K/Akt and apoptosis: size matters
Franke, T. F., Hornik, C. P., Segev, L., Shostak, G. A., & Sugimoto, C. (2003) · Oncogene · doi:10.1038/sj.onc.1207115 · Cited by 1,184
Yang, H., Kong, W., He, L., Zhao, J.-J., O'Donnell, J. D., Wang, J., Wenham, R. M., Coppola, D., Kruk, P. A., Nicosia, S. V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2488 · Cited by 1,051
FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis
Paik, J.-H., Kollipara, R., Chu, G., Ji, H., Xiao, Y., Ding, Z., Miao, L., Tothova, Z., Horner, J. W., Carrasco, D. R., et al. (2007) · Cell · doi:10.1016/j.cell.2006.12.029 · Cited by 1,032
Seoane, J., Le, H.-V., Shen, L., Anderson, S. A., & Massagué, J. (2004) · Cell · doi:10.1016/s0092-8674(04)00298-3 · Cited by 1,028
Dijkers, P. F., Medema†, R. H., Lammers, J.-W. J., Koenderman, L., & Coffer, P. J. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00728-4 · Cited by 976
Frasor, J., Danes, J. M., Komm, B., Chang, K. C. N., Lyttle, C. R., & Katzenellenbogen, B. S. (2003) · Endocrinology · doi:10.1210/en.2003-0567 · Cited by 876
IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a
Hu, M. C.-T., Lee, D.-F., Xia, W., Golfman, L. S., Ou-Yang, F., Yang, J.-Y., Zou, Y., Bao, S., Hanada, N., Saso, H., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00302-2 · Cited by 868
Stressing the role of FoxO proteins in lifespan and disease
van der Horst, A., & Burgering, B. M. T. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2190 · Cited by 759
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
Yang, J.-Y., Zong, C. S., Xia, W., Yamaguchi, H., Ding, Q., Xie, X., Lang, J.-Y., Lai, C.-C., Chang, C.-J., Huang, W.-C., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1676 · Cited by 697
Nutrient Availability Regulates SIRT1 Through a Forkhead-Dependent Pathway
Nemoto, S., Fergusson, M. M., & Finkel, T. (2004) · Science · doi:10.1126/science.1101731 · Cited by 677
Cell cycle and death control: long live Forkheads
Burgering, B. M. T., & Kops, G. J. P. L. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)02113-8 · Cited by 647
Gilley, J., Coffer, P. J., & Ham, J. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200303026 · Cited by 645
Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK
Dan, H. C., Cooper, M. J., Cogswell, P. C., Duncan, J. A., Ting, J. P.-Y., & Baldwin, A. S. (2008) · Genes & Development · doi:10.1101/gad.1662308 · Cited by 636
Dijkers, P. F., Medema, R. H., Pals, C., Banerji, L., Thomas, N. S. B., Lam, E. W.-F., Burgering, B. M. T., Raaijmakers, J. A. M., Lammers, J.-W. J., Koenderman, L., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9138-9148.2000 · Cited by 617
Stahl, M., Dijkers, P. F., Kops, G. J. P. L., Lens, S. M. A., Coffer, P. J., Burgering, B. M. T., & Medema, R. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5024 · Cited by 585
Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.
Davis, R. J., D’Cruz, C. M., Lovell, M. A., Biegel, J. A., & Barr, F. G. (1994) · PubMed · Cited by 585
FOXOs, cancer and regulation of apoptosis
Fu, Z., & Tindall, D. J. (2008) · Oncogene · doi:10.1038/onc.2008.24 · Cited by 584
cell cycle and death control: long live Forkheads
Burgering, B., Medema, R., & Kops, G. (2002) · GBM Annual Fall meeting Halle 2002 · doi:10.1240/sav_gbm_2002_h_000075 · Cited by 584
TGF-β activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN
Kato, M., Putta, S., Wang, M., Yuan, H., Lanting, L., Nair, I., Gunn, A., Nakagawa, Y., Shimano, H., Todorov, I., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1897 · Cited by 573
Cell Cycle Inhibition by FoxO Forkhead Transcription Factors Involves Downregulation of Cyclin D
Schmidt, M., Fernandez de Mattos, S., van der Horst, A., Klompmaker, R., Kops, G. J. P. L., Lam, E. W.-F., Burgering, B. M. T., & Medema, R. H. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.22.7842-7852.2002 · Cited by 562
Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation
Matsuzaki, H., Daitoku, H., Hatta, M., Tanaka, K., & Fukamizu, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934283100 · Cited by 535
Sunters, A., Fernández de Mattos, S., Stahl, M., Brosens, J. J., Zoumpoulidou, G., Saunders, C. A., Coffer, P. J., Medema, R. H., Coombes, R. C., & Lam, E. W.-F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309523200 · Cited by 505
Raymond, E., Alexandre, J., Faivre, S., Vera, K., Materman, E., Boni, J., Leister, C., Korth-Bradley, J., Hanauske, A., & Armand, J.-P. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.116 · Cited by 499
Drug discovery approaches targeting the PI3K/Akt pathway in cancer
Garcia-Echeverria, C., & Sellers, W. R. (2008) · Oncogene · doi:10.1038/onc.2008.246 · Cited by 473
BH3-only proteins in apoptosis and beyond: an overview
Lomonosova, E., & Chinnadurai, G. (2008) · Oncogene · doi:10.1038/onc.2009.39 · Cited by 458
Control of Cell Cycle Exit and Entry by Protein Kinase B-Regulated Forkhead Transcription Factors
Kops, G. J. P. L., Medema, R. H., Glassford, J., Essers, M. A. G., Dijkers, P. F., Coffer, P. J., Lam, E. W.-F., & Burgering, B. M. T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2025-2036.2002 · Cited by 442
MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor
Li, J., Huang, H., Sun, L., Yang, M., Pan, C., Chen, W., Wu, D., Lin, Z., Zeng, C., Yao, Y., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3053 · Cited by 434
Huse, J. T., Brennan, C., Hambardzumyan, D., Wee, B., Pena, J., Rouhanifard, S. H., Sohn-Lee, C., le Sage, C., Agami, R., Tuschl, T., et al. (2009) · Genes & Development · doi:10.1101/gad.1777409 · Cited by 431
A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR
Ramaswamy, S., Nakamura, N., Sansal, I., Bergeron, L., & Sellers, W. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00086-7 · Cited by 428
FOXO3a-dependent regulation of Puma in response to cytokine/growth factor withdrawal
You, H., Pellegrini, M., Tsuchihara, K., Yamamoto, K., Hacker, G., Erlacher, M., Villunger, A., & Mak, T. W. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060353 · Cited by 412
Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation.
Kondapaka, S. B., Singh, S. S., Dasmahapatra, G. P., Sausville, E. A., & Roy, K. (2003) · PubMed · Cited by 407
Identification of a tumour suppressor network opposing nuclear Akt function
Trotman, L. C., Alimonti, A., Scaglioni, P. P., Koutcher, J. A., Cordon-Cardo, C., & Pandolfi, P. P. (2006) · Nature · doi:10.1038/nature04809 · Cited by 394
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma
Barr, F. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204599 · Cited by 383
Chun-zhi, Z., Lei, H., An-ling, Z., Yan-chao, F., Xiao, Y., Guang-xiu, W., Zhi-fan, J., Pei-yu, P., Qing-yu, Z., & Chun-sheng, K. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-367 · Cited by 382
FOXO Proteins Regulate Tumor Necrosis Factor-related Apoptosis Inducing Ligand Expression
Modur, V., Nagarajan, R., Evers, B. M., & Milbrandt, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207509200 · Cited by 371
FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal
Dijkers, P. F., Birkenkamp, K. U., Lam, E. W.-F., Thomas, N. S. B., Lammers, J.-W. J., Koenderman, L., & Coffer, P. J. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108084 · Cited by 363
The role of PTEN signaling perturbations in cancer and in targeted therapy
Keniry, M., & Parsons, R. (2008) · Oncogene · doi:10.1038/onc.2008.248 · Cited by 358
Cloning and Characterization of Three Human Forkhead Genes That Comprise an FKHR-like Gene Subfamily
Anderson, M. J., Viars, C. S., Czekay, S., Cavenee, W. K., & Arden, K. C. (1998) · Genomics · doi:10.1006/geno.1997.5122 · Cited by 357
FoxO Transcription Factors and Stem Cell Homeostasis: Insights from the Hematopoietic System
Tothova, Z., & Gilliland, D. G. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.07.017 · Cited by 331
Kau, T. R., Schroeder, F., Ramaswamy, S., Wojciechowski, C. L., Zhao, J. J., Roberts, T. M., Clardy, J., Sellers, W. R., & Silver, P. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00303-9 · Cited by 329
Insulin-Like Signaling, Nutrient Homeostasis, and Life Span
Taguchi, A., & White, M. F. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100533 · Cited by 310
Novel Agents on the Horizon for Cancer Therapy
Ma, W. W., & Adjei, A. A. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20003 · Cited by 304
Essafi, A., Fernández de Mattos, S., Hassen, Y. A. M., Soeiro, I., Mufti, G. J., Thomas, N. S. B., Medema, R. H., & Lam, E. W.-F. (2005) · Oncogene · doi:10.1038/sj.onc.1208421 · Cited by 293
Park, J.-K., Lee, E. J., Esau, C., & Schmittgen, T. D. (2009) · Pancreas · doi:10.1097/mpa.0b013e3181ba82e1 · Cited by 287
Forkhead transcription factors contribute to execution of the mitotic programme in mammals
Alvarez, B., Martínez-A., C., Burgering, B. M. T., & Carrera, A. C. (2001) · Nature · doi:10.1038/35099574 · Cited by 277
Unravelling the tumor-suppressive functions of FOXO proteins
Dansen, T. B., & Burgering, B. M. T. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.07.004 · Cited by 268
Sunters, A., Madureira, P. A., Pomeranz, K. M., Aubert, M., Brosens, J. J., Cook, S. J., Burgering, B. M. T., Coombes, R. C., & Lam, E. W.-F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1997 · Cited by 249
Apoptosis: biochemical aspects and clinical implications
Kiechle, F. L., & Zhang, X. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00297-8 · Cited by 249
Self-citationPI(3)King Apart PTEN's Role in Cancer
Zhang, S., & Yu, D. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2990 · Cited by 248
A FoxO–Smad synexpression group in human keratinocytes
Gomis, R. R., Alarcón, C., He, W., Wang, Q., Seoane, J., Lash, A., & Massagué, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605333103 · Cited by 246
Insulin‐like growth factor ligands, receptors, and binding proteins in cancer
Foulstone, E., Prince, S., Zaccheo, O., Burns, J., Harper, J., Jacobs, C., Church, D., & Hassan, A. (2005) · The Journal of Pathology · doi:10.1002/path.1712 · Cited by 245
Borkhardt, A., Repp, R., Haas, O. A., Leis, T., Harbott, J., Kreuder, J., Hammermann, J., Henn, T., & Lampert, F. (1997) · Oncogene · doi:10.1038/sj.onc.1200814 · Cited by 238
Akt inhibitors in clinical development for the treatment of cancer
Pal, S. K., Reckamp, K., Yu, H., & Figlin, R. A. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.520701 · Cited by 226
Tang, T. T.-L., Dowbenko, D., Jackson, A., Toney, L., Lewin, D. A., Dent, A. L., & Lasky, L. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110901200 · Cited by 223
Gluecksohn-Waelsch, S. (1979) · Cell · doi:10.1016/0092-8674(79)90001-1 · Cited by 218
Ren, Y., Zhou, X., Mei, M., Yuan, X.-B., Han, L., Wang, G.-X., Jia, Z.-F., Xu, P., Pu, P.-Y., & Kang, C.-S. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-27 · Cited by 216
FOXO transcription factors: key regulators of cell fate
Lam, E. W.-F., Francis, R. E., & Petkovic, M. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340722 · Cited by 215
Urbich, C., Knau, A., Fichtlscherer, S., Walter, D. H., Brühl, T., Potente, M., Hofmann, W. K., De Vos, S., Zeiher, A. M., & Dimmeler, S. (2005) · The FASEB Journal · doi:10.1096/fj.04-2727fje · Cited by 200
P53 is a tumor suppressor gene
Levine, A. J., Finlay, C. A., & Hinds, P. W. (2004) · Cell · doi:10.1016/s0092-8674(04)00036-4 · Cited by 185
The AMPK-FoxO3A axis as a target for cancer treatment
Chiacchiera, F., & Simone, C. (2010) · Cell Cycle · doi:10.4161/cc.9.6.11035 · Cited by 170
Ihle, N. T., & Powis, G. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0801 · Cited by 168
Li, P., Lee, H., Guo, S., Unterman, T. G., Jenster, G., & Bai, W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.104-118.2003 · Cited by 160
Liu, P., Kao, T. P., & Huang, H. (2008) · Oncogene · doi:10.1038/onc.2008.104 · Cited by 158
Resistance May Not Be Futile: microRNA Biomarkers for Chemoresistance and Potential Therapeutics
Allen, K. E., & Weiss, G. J. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0397 · Cited by 158
Ernst, A., Campos, B., Meier, J., Devens, F., Liesenberg, F., Wolter, M., Reifenberger, G., Herold-Mende, C., Lichter, P., & Radlwimmer, B. (2010) · Oncogene · doi:10.1038/onc.2010.83 · Cited by 147
Barnett, S., Bilodeau, M. T., & Lindsley, C. W. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026053507714 · Cited by 146
SnapShot:Forkhead Transcription Factors I
Tuteja, G., & Kaestner, K. H. (2007) · Cell · doi:10.1016/j.cell.2007.09.005 · Cited by 145
miR-22 Forms a Regulatory Loop in PTEN/AKT Pathway and Modulates Signaling Kinetics
Bar, N., & Dikstein, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010859 · Cited by 137
SnapShot: Forkhead Transcription Factors II
Tuteja, G., & Kaestner, K. H. (2007) · Cell · doi:10.1016/j.cell.2007.09.016 · Cited by 120
Zeng, Z., Samudio, I. J., Zhang, W., Estrov, Z. E., Pelicano, H., Harris, D., Frolova, O., Hail, N., Chen, W., Kornblau, S. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1278 · Cited by 115
Arden, K. C. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00213-8 · Cited by 113
The function of p27 KIP1 during tumor development
Lee, J., & Kim, S. S. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.11.102 · Cited by 112
Song, L., Wang, L., Li, Y., Xiong, H., Wu, J., Li, J., & Li, M. (2010) · The Journal of Pathology · doi:10.1002/path.2751 · Cited by 108
Chipuk, J. E., & Green, D. R. (2009) · Cell Cycle · doi:10.4161/cc.8.17.9412 · Cited by 106
Liu, L., Jiang, Y., Zhang, H., Greenlee, A. R., & Han, Z. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.12.002 · Cited by 105
Rationale and clinical application of alkylphospholipid analogues in combination with radiotherapy
Vink, S. R., BLITTERSWIJK, W. J. V., Schellens, J. H. M., & Verheij, M. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.12.001 · Cited by 104
Differential Expression of PTEN-Targeting MicroRNAs miR-19a and miR-21 in Cowden Syndrome
Pezzolesi, M. G., Platzer, P., Waite, K. A., & Eng, C. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.04.005 · Cited by 101
So, C. W. E., & Cleary, M. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.18.6542-6552.2002 · Cited by 101
Pandini, G., Médico, E., Conte, E., Sciacca, L., Vigneri, R., & Belfiore, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304980200 · Cited by 94
Guanine nucleotide exchange factors of the cytohesin family and their roles in signal transduction
Kolanus, W. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00542.x · Cited by 91
Targeted therapies in breast cancer: Where are we now?
Cosimo, S. D., & Baselga, J. M. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.09.026 · Cited by 90
Tang, T. T.-L., & Lasky, L. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302042200 · Cited by 88
The Applicability of mTOR Inhibition in Solid Tumors
Konings, I. R. H. M., Verweij, J., Wiemer, E. A. C., & Sleijfer, S. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909788166556 · Cited by 84
Ward, E. C., Hoekstra, A. V., Blok, L. J., Hanifi‐Moghaddam, P., Lurain, J. R., Singh, D. K., Buttin, B. M., Schink, J. C., & Kim, J. J. (2007) · Endocrinology · doi:10.1210/en.2007-0756 · Cited by 83
IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia
Chapuis, N., Park, S., Léotoing, L., Tamburini, J., Verdier, F., Bardet, V., Green, A. S., Willems, L., Agou, F., Ifrah, N., et al. (2010) · Blood · doi:10.1182/blood-2009-12-260711 · Cited by 82
Cornforth, A. N., Davis, J. S., Khanifar, E., Nastiuk, K. L., & Krolewski, J. J. (2008) · Oncogene · doi:10.1038/onc.2008.80 · Cited by 77
FoxO tumor suppressors and BCR–ABL-induced leukemia: A matter of evasion of apoptosis
Jagani, Z., Singh, A. J., & Khosravi‐Far, R. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.10.003 · Cited by 75
FOXO transcription factor-dependent p15INK4b and p19INK4d expression
Katayama, K., Nakamura, A., Sugimoto, Y., TSURUO, T., & Fujita, N. (2007) · Oncogene · doi:10.1038/sj.onc.1210813 · Cited by 75
The CNK1 scaffold binds cytohesins and promotes insulin pathway signalingPreprint
Lim, J.-H., Zhou, M., Veenstra, T. D., et al. (2010) · Genes & Development · doi:10.1101/gad.1904610 · Cited by 71
Cyclin G2 Dysregulation in Human Oral Cancer
Kim, Y., Shintani, S., Kohno, Y., Zhang, R., & Wong, D. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1926 · Cited by 68
Tat-Induced FOXO3a Is a Key Mediator of Apoptosis in HIV-1-Infected Human CD4+ T Lymphocytes
Dabrowska, A., Kim, N., & Aldovini, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8460 · Cited by 59
Ito, K., Bernardi, R., & Pandolfi, P. P. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.01.004 · Cited by 53
Kikuchi, S., Nagai, T., Kunitama, M., Kirito, K., Ozawa, K., & Komatsu, N. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00623.x · Cited by 52
Whether to target single or multiple CDKs for therapy? That is the question
Węsierska‐Gądek, J., Maurer‐Granofszky, M., Zulehner, N., & Komina, O. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22426 · Cited by 50
Park, S.-J., Sohn, H., Yoon, J., & Park, S. I. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.05.008 · Cited by 49
Jagani, Z., Song, K., Kutok, J. L., Dewar, M. R., Melet, A., Santos, T., Grassian, A. R., Ghaffari, S., Wu, C. J., Ren, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0605 · Cited by 48
Gómez-Gutiérrez, J. G., Souza, V., Hao, H., Montes‐de‐Oca‐Luna, R., Dong, Y., Zhou, H., & McMasters, K. M. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.7.2911 · Cited by 47
Posttranscriptional Regulation of PTEN Dosage by Noncoding RNAs
He, L. (2010) · Science Signaling · doi:10.1126/scisignal.3146pe39 · Cited by 46
Cell death pathways – potential therapeutic targets
MacFarlane, M. (2009) · Xenobiotica · doi:10.1080/00498250903137990 · Cited by 46
Mikse, O. R., Blake, D. C., Jones, N. R., Sun, Y., Amin, S., Gallagher, C. J., Lazarus, P. J., Weisz, J., & Herzog, C. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4008 · Cited by 40
Fritz, R. D., Varga, Z., & Radziwill, G. (2010) · Oncogene · doi:10.1038/onc.2010.104 · Cited by 38
Deng, R., Tang, J., Xie, B., Feng, G., Huang, Y., Liu, Z., & Zhu, X. (2009) · International Journal of Cancer · doi:10.1002/ijc.25032 · Cited by 38
Inhibitors of phosphatidylinositol-3-kinase in cancer therapy
Ihle, N. T., & Powis, G. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.02.003 · Cited by 37
Microarray Data Mining for Potential Selenium Targets in Chemoprevention of Prostate Cancer.
Zhang, H., Dong, Y., Zhao, H., Brooks, J. D., Hawthorn, L., Nowak, N. J., Marshall, J. R., Gao, A. C., & Ip, C. C. Y. (2005) · PubMed · Cited by 37
CNK1 Promotes Invasion of Cancer Cells through NF-κB–Dependent Signaling
Fritz, R. D., & Radziwill, G. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0296 · Cited by 35
Expression Levels of Cyclin G2, But Not Cyclin E, Correlate With Gastric Cancer Progression
Choi, M.-G., Noh, J. H., An, J. Y., Hong, S. K., Park, S. B., Baik, Y. H., Kim, K., Sohn, T. S., & Kim, S. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.06.020 · Cited by 35
Ito, Y., Yoshida, H., Uruno, T., Nakano, K., Takamura, Y., Miya, A., Kobayashi, K., Yokozawa, T., Matsuzuka, F., Kuma, K., et al. (2003) · PubMed · Cited by 35
van Duijn, P. W., der Made, A. C. J. Z.-V., van der Korput, J. A. G. M., & Trapman, J. (2009) · The Prostate · doi:10.1002/pros.21045 · Cited by 34
Expression and intracellular localization of FKHRL1 in mammary gland neoplasms.
Jin, G.-S., Kondo, E., Miyake, T., Shibata, M. S., Takashima, T., Liu, Y.-X., Hayashi, K., Akagi, T., & Yoshino, T. (2004) · PubMed · doi:10.18926/amo/32088 · Cited by 29
Blake, D. C., Mikse, O. R., Freeman, W. M., & Herzog, C. R. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.03.013 · Cited by 29
Zhang, H., Fang, J., Yao, D., Wu, Y., Ip, C. C. Y., & Dong, Y. (2010) · The Prostate · doi:10.1002/pros.21162 · Cited by 22
FoxO3a gene is a target of deletion in mouse lung adenocarcinoma
Herzog (2009) · Oncology Reports · doi:10.3892/or_00000507 · Cited by 13
Targeting of Apoptosis Signaling Pathways and Their Mediators for Cancer Therapy
Rishi, A. K., Zhang, X., & Wali, A. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0131-6_5 · Cited by 4
Self-citation
Cited by
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Glaviano, A., Foo, A. S. C., Lam, H. Y., Yap, K. C. H., Jacot, W., Jones, R. H., Eng, H., Nair, M. G., Makvandi, P., Geoerger, B., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01827-6 · Cited by 2,138
Phosphoinositides: Tiny Lipids With Giant Impact on Cell Regulation
Balla, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00028.2012 · Cited by 1,638
Sever, R., & Brugge, J. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006098 · Cited by 989
The sirtuin family in health and disease
Wu, Q.-J., Zhang, T.-N., Chen, H.-H., Yu, X.-F., Lv, J.-L., Liu, Y.-Y., Liu, Y.-S., Zheng, G., Zhao, J.-Q., Wei, Y.-F., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01257-8 · Cited by 862
Specificity, versatility, and control of TGF-β family signaling
Derynck, R., & Budi, E. H. (2019) · Science Signaling · doi:10.1126/scisignal.aav5183 · Cited by 785
Metadata
- Authors
- Zhang, X., Tang, N., Hadden, T. J., & Rishi, A. K.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 1813
- Issue
- 11
- Pages
- 1978-1986
- ISSN
- 0167-4889 (ISSN-L)
- OpenAlex
- W2156563694
- Cited by
- 1,103
- References
- 136
- FWCI
- 15.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.